1. Home
  2. STIM vs RCEL Comparison

STIM vs RCEL Comparison

Compare STIM & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.05

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$5.29

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
RCEL
Founded
2003
N/A
Country
United States
United States
Employees
N/A
226
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.5M
126.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STIM
RCEL
Price
$2.05
$5.29
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$3.00
$7.88
AVG Volume (30 Days)
1.4M
358.7K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
$17.17
Revenue Next Year
$11.92
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$3.22
52 Week High
$4.84
$7.12

Technical Indicators

Market Signals
Indicator
STIM
RCEL
Relative Strength Index (RSI) 69.59 64.56
Support Level $1.21 $3.55
Resistance Level $2.19 $5.32
Average True Range (ATR) 0.22 0.45
MACD 0.04 0.08
Stochastic Oscillator 71.90 73.53

Price Performance

Historical Comparison
STIM
RCEL

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: